The current RXRX market cap is 3.1B. The company's latest EPS is USD -1.1445 and P/E is -9.30.
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 2.32M | 3.96M | 10.18M | 39.84M | 44.58M |
Operating Income | -62.44M | -84.38M | -182.78M | -245.73M | -350.06M |
Net Income | -61.88M | -87.01M | -186.48M | -239.48M | -328.07M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 101.43M | 298.59M | 610.35M | 701.29M | 653.7M |
Total Liabilities | 24.59M | 56.56M | 67.41M | 215.48M | 190.26M |
Total Equity | -124.27M | -206.29M | 542.94M | 485.81M | 463.44M |
Market Cap | 3.1B |
Price to Earnings Ratio | -9.30 |
Price to Sales Ratio | 68.42 |
Price to Cash Ratio | 7.79 |
Price to Book Ratio | 6.58 |
Dividend Yield | - |
Shares Outstanding | 286.64M |
Average Volume (1 week) | 51.44M |
Average Volume (1 Month) | 29.58M |
52 Week Change | -17.01% |
52 Week High | 15.74 |
52 Week Low | 5.61 |
Spread (Intraday) | 0.01 (0.09%) |
Company Name | Recursion Pharmaceuticals Inc |
Address |
1209 orange street wilmington, delaware 19801 |
Website | https://www.recursion.com |
Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions